Sofwave is an ultrasound device developed by Sofwave Medical in Israel. Its proprietary “SUPERB™” technology simultaneously delivers seven ultrasound beams directly to the mid-dermis, an area that was difficult to treat with conventional methods, encouraging the production of collagen and elastin. The treatment aims to tighten the skin and improve firmness.
Because the skin’s surface can be cooled during treatment, it is also characterized by its ability to help minimize damage to the skin surface. In addition to FDA approval, it received approval from Japan’s Ministry of Health, Labour and Welfare in 2025.
For more details about Sofwave, please see the following article.